Daymark Wealth Partners’s Sanofi SNY Stock Holding History

Daymark Wealth Partners’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,738	Closed	-$230K	–	755
2025 Q4	$230K	Sell	4,738 -74	-2%	-$3.67K	0.01%	553
2025 Q3	$227K	Buy	+4,812	New	+$232K	0.01%	560

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Daymark Wealth Partners's SNY Position: Q1 2026 in Review

Daymark Wealth Partners sold out of Sanofi (SNY) in Q1 2026, closing a stake of 4,738 shares — an estimated $230K sold.

Daymark Wealth Partners first reported a position in SNY in Q3 2025 and held it in 2 quarters. The position peaked at $230K in Q4 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

Daymark Wealth Partners reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
Daymark Wealth Partners sold 4,738 Sanofi shares in Q1 2026, an estimated $230K.
Daymark Wealth Partners first reported a position in Sanofi in Q3 2025 and held it in 2 quarters.
Daymark Wealth Partners's Sanofi position peaked at $230K in Q4 2025.
737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Daymark Wealth Partners's 13F filing for Q1 2026, filed 11 May 2026.